| |
| |
|
| Insider
Information: |
Deerfield International Master Fund, L.p. |
| Relationship: |
*Director by Deputizat... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
285,000 |
|
|
Indirect Shares
|
28,566,834 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$91,142,405 |
|
|
| Total
Shares |
28,851,834 |
|
|
| Total
Value |
$91,142,405 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ehealth, Inc. |
EHTH |
Possible Members of 10... |
2014-08-01 |
0 |
2017-04-27 |
877,606 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
Possible Members of 10... |
2014-08-05 |
0 |
2014-08-05 |
627,267 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
Possible Members of 10... |
2014-08-06 |
0 |
2014-08-06 |
296,125 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2015-05-15 |
4,784,157 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Possible Member of 10%... |
2015-06-11 |
0 |
2015-07-20 |
9,500,803 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Possible Member of 10%... |
2016-02-09 |
0 |
2016-02-11 |
2,039,360 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Possible Member of 10%... |
2016-02-11 |
75,000 |
2016-02-19 |
9,414,041 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
10% Owner |
2016-02-17 |
210,000 |
|
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
*Director by Deputizat... |
2017-11-30 |
0 |
2017-11-30 |
1,027,475 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
S |
$1.75 |
$193,475 |
I/I |
(110,557) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
B |
$1.75 |
$193,475 |
I/I |
110,557 |
197,424 |
1.5 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-27 |
4 |
S |
$11.71 |
$3,673,532 |
I/I |
(313,709) |
877,606 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-26 |
4 |
S |
$11.52 |
$1,304,582 |
I/I |
(113,245) |
949,443 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-13 |
4 |
S |
$11.00 |
$1,650,000 |
I/I |
(150,000) |
975,375 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-11 |
4 |
S |
$11.01 |
$368,258 |
I/I |
(33,440) |
1,009,724 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-10 |
4 |
S |
$11.04 |
$880,318 |
I/I |
(79,757) |
1,017,382 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-07 |
4 |
S |
$11.72 |
$1,393,115 |
I/I |
(118,904) |
1,035,646 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-21 |
4 |
S |
$14.30 |
$377,552 |
I/I |
(26,400) |
718,594 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-20 |
4 |
S |
$14.20 |
$2,533,511 |
I/I |
(178,454) |
744,994 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-14 |
4 |
S |
$13.88 |
$601,169 |
I/I |
(43,300) |
923,448 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-08 |
4 |
S |
$13.84 |
$388,633 |
I/I |
(28,080) |
966,748 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-07 |
4 |
S |
$13.89 |
$99,380 |
I/I |
(7,154) |
994,828 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-06 |
4 |
S |
$14.00 |
$399,037 |
I/I |
(28,502) |
1,001,982 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-02 |
4 |
S |
$13.87 |
$591,741 |
I/I |
(42,668) |
1,030,484 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-06-01 |
4 |
S |
$13.80 |
$69 |
I/I |
(5) |
1,073,152 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-05-31 |
4 |
S |
$13.84 |
$786,625 |
I/I |
(56,835) |
1,073,157 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-05-27 |
4 |
S |
$14.00 |
$1,016,926 |
I/I |
(72,649) |
1,129,992 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-05-26 |
4 |
S |
$14.16 |
$1,330,808 |
I/I |
(93,965) |
1,202,641 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2016-05-25 |
4 |
S |
$14.25 |
$655,172 |
I/I |
(45,967) |
1,296,606 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Possible Member of 10% Group |
– – • |
2016-02-19 |
4 |
B |
$3.99 |
$83,647 |
I/I |
20,973 |
2,746,650 |
1.5 |
- |
|
| AVXS |
Avexis, Inc. |
10% Owner |
– – • |
2016-02-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
210,000 |
|
- |
|
| XNPT |
Xenoport Inc |
Possible Member of 10% Group |
– – • |
2016-02-12 |
4 |
B |
$3.92 |
$138,184 |
I/I |
35,224 |
2,734,905 |
1.5 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Possible Member of 10% Group |
– – • |
2016-02-11 |
4 |
B |
$6.19 |
$14,506 |
I/I |
2,344 |
2,039,360 |
1.5 |
- |
|
| XNPT |
Xenoport Inc |
Possible Member of 10% Group |
– – • |
2016-02-11 |
4 |
B |
$3.76 |
$18,779,437 |
I/I |
4,848,537 |
2,715,180 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
